Chris Nolet - Insider Trading & Ownership

Entity
Individual
Location
C/O Revance Therapeutics, Inc., 7555 Gateway Boulevard, Newark, CA
Summary
The estimated net worth of Chris Nolet is at least $177K dollars as of June 10, 2024. Chris Nolet is the Director of Revance Therapeutics, Inc. and owns shares of Revance Therapeutics, Inc. (RVNC) stock worth about $166K. Chris Nolet is the Director of POLARITYTE, INC. and owns shares of POLARITYTE, INC. (PTEIQ) stock worth about $11.4K.
All Insider Reports
All Insider Reports

Ownership of Chris Nolet

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RVNC Revance Therapeutics, Inc. Director $166K May 1, 2024
PTEIQ POLARITYTE, INC. Director $11.4K Jan 12, 2023
AVBP ArriVent BioPharma, Inc. Director Jan 25, 2024
JSPR, JSPRW Jasper Therapeutics, Inc. Director Jun 6, 2024

Insider Transactions Reported by Chris Nolet:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.